On July 17, 2018, the Food and Drug Administration approved a new single tablet regimen (STR) for treating chronic HIV, called Symtuza. The once-a-day, full-regimen pill contains four drugs: the protease inhibitor darunavir (Prezista) + the booster cobicistat (Tybost) + the NRTIs emtricitabine (FTC/Emtriva) and tenofovir…Read More
Issued by the California Department of Public Health on July 5, 2018: Many organizations and programs in California can help reduce deaths associated with opioid overdose by distributing naloxone, however some find it difficult to obtain the required standing order from a physician to do so….Read More
July 5, 2018
New Medi-Cal policy issued for treating hepatitis C
On July 3, 2018, California Department of Public Health issued the following communication. Dear Community Partners: I am very excited to announce that today the California Department of Health Care Services (DHCS) released a new hepatitis C treatment policy for Medi-Cal beneficiaries. The new Medi-Cal policy…Read More
ORIGINAL POST: www.nastad.org Every year during our Annual Meeting, NASTAD celebrates the accomplishments of our members and partners with a series of awards. This year, we’re so proud to recognize the amazing accomplishments of Peter Whiticar, Diana Jordan, Anne Donnelly, and Dr. Theo Hodge. NASTAD Partnership…Read More
There has been an increase in HIV cure-related research in the recent years. Many approaches are being investigated in the United States and other countries. Go to the survey here: http://bit.ly/2DoCx8e. The Gillings School of Global Public Health at UNC and Project Inform would like to find…Read More
The Board of Directors of Project Inform is announcing today the upcoming departure of Dana Van Gorder as Executive Director on June 30, 2018, after successfully leading Project Inform for over 10 years. With the upcoming leadership transition, the Board has appointed David Evans to the…Read More
Reprinted from HepMag.com. On Friday, May 11, 2018, Governor Jerry Brown of California released his “May Revised Budget” and it contained a lot of excellent news for people living with hepatitis C (HCV): Called for the removal of all fibrosis restrictions in Medi-Cal; Added $70.4 million…Read More